Cellular absorption of anthraquinones emodin and chrysophanol in human intestinal Caco-2 cells

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 7, 2007, Pages 1636-1643

  Teng, Zeng Hui ^a   Zhou, Si Yuan ^a   Ran, Yu Hua ^a   Liu, Xin You ^a,b   Yang, Run Tao ^a   Yang, Xi ^a   Yuan, Cheng Jun ^a   Mei, Qi Bing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Caco 2 cell; Chrysophanol; Emodin; Intestinal absorption

Indexed keywords

ABSORPTION; CELLS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTEINS;

CHRYSOPHANOL; EMODIN; INTESTINAL ABSORPTION;

DRUG PRODUCTS;

ANTHRAQUINONE DERIVATIVE; CHRYSOPHANIC ACID; EMODIN; ENZYME INHIBITOR; MUTAGENIC AGENT;

ARTICLE; CELL STRAIN CACO 2; CYTOLOGY; HUMAN; INTESTINE; METABOLISM;

ANTHRAQUINONES; CACO-2 CELLS; EMODIN; ENZYME INHIBITORS; HUMANS; INTESTINES; MUTAGENS;

EID: 34548431270     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70025     Document Type: Article

References (25)

1. Manach, C., Williamson, G., Morand, C., Scalbert, A., and Remesy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clini. Nutr., 81, 230S-242S (2005).
2. DuPont, M. S., Bennett, R. N., Mellon, F. A., and Williamson, G., Polyphenols from alcoholic apple cider are absorbed, metabolized and excreted by humans. J. Nutr., 132, 172-175 (2002).
3. Mueller, S. O., Schmitt, M., Dekant, W., Stopper, H., Schlatter, J., Schreier, P., and Lutz, W. K., Occurrence of emodin, chrysophanol and physcion in vegetables, herbs and liquors. Genotoxicity and anti-genotoxicity of the anthraquinones and of the whole plants. Food Chem. Toxicol., 37, 481-491 (1999).
4. Fratta, D., Simi, S., Rainaldi, G., and Gervasi, P. G., Role of cytochrome P-450 isoenzymes in the bioactivation of hydroxy anthraquinones. Anticancer Res., 14, 2597-2603 (1994).
5. Wang, H. W., Chen, T. L., Yang, P. C., and Ueng, T. H., Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. Drug Metab. Dispos., 29, 1229-1235 (2001).
6. Mueller, S. O., Stopper, H., and Dekan, W., Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes, bioactivation to genotoxic metabolites. Drug Metab. Dispos., 26, 540-546 (1998).
7. Liang, J. W., Hsiu, S. L., Wu, P. P., and Chao, P. D., Emodin pharmacokinetics in rabbits. Planta Med., 61, 406-408 (1995).
8. Huang, Q., Shen, H. M., and Ong, C. N., Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem. Pharmacol., 68, 361-371 (2004).
9. Semple, S. J., Pyke, S. M., Reynolds, G. D., and Flower, R. L., In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. Antiviral Res., 49, 169-178 (2001).
10. Krau, C., and Hesse, A., Pharmacokinetics and bioavailability of madder anthraquinones - an investigation by HPLC. Anal. Bioanal. Chem., 343, 111-112 (1992).
11. Kim, D. H., Park, E. K., Bae, E. A., and Han, M. J., Metabolism of rhaponticin and chrysophanol 8-o-beta-D-glucopyranoside from the rhizome of Rheum undulatum by human intestinal bacteria and their anti-allergic actions. Biol. Pharm. Bull., 23, 830-833 (2000).
12. Sugawara, T., Kinoshita, M., and Saito, M., Efflux of sphingoid bases by P-Glycoprotein in human intestinal Caco-2 cells. Biosci. Biotechnol. Biochem., 68, 2541-2546 (2004).
13. Wang, Y., Cao, J., and Zeng, S., Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J. Pharm. Pharmacol., 57, 751-758 (2005).
14. Rodriguez, I., Abernethy, D. R., and Woosley, R. L., P-glycoprotein in clinical cardiology. Circulation, 99, 472-474 (1999).
15. Cermak, R., Landgraf, S., and Wolffram, S., Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr., 91, 849-855 (2004).
16. Yokomizo, A., and Moriwaki, M., Transepithelial permeability of myricitrin and its degradation by simulated digestion in human intestinal Caco-2 cell monolayer. Biosci. Biotechnol. Biochem., 69, 1774-1776 (2005).
17. Hidalgo, I. J., Raub, T. J., and Borchardt, R. T., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749 (1989).
18. Liu, Y., and Hu, M., Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perfused rat intestinal model. Drug Metab. Dispos., 30, 370-377 (2002).
19. Vaidyanathan, J., and Walle, T., Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2. The Journal of Pharmacology and Experimental Therapeutics., 307, 745-752 (2003).
20. Johnston, K., Sharp, P., Clifford, M., and Morgan, L., Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett., 579, 1653-1657 (2005).
21. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
22. Toggenburger, G., Kessler, M., and Semenza, G., Phlorizin as a probe of the small-intestinal Na1, D-glucose cotransporter. A model. Biochim. Biophys. Acta, 688, 557-571 (1982).
23. Geleijnse, J. M., Launer, L. J., Van, D. A., Hofman, A., and Witteman, J. C., Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am. J. Clin. Nutr., 75, 880-886 (2002).
24. Itoh, T., Itagaki, S., Sumi, Y., Hirano, T., Takemoto, I., and Iseki, K., Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2. Cancer Chemother. Pharmacol., 55, 420-424 (2005).
25. Vereczkey, L., Jemnitz, K., Monostory, K., Veres, Z., and Kobori, L., The role of drug metabolizing enzymes in the effect and side-effect of the drugs. Orv. Hetil., 146, 947-952 (2005).